Working… Menu
Trial record 6 of 1545 for:    Androgens

Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2 (FASTR-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02229734
Recruitment Status : Active, not recruiting
First Posted : September 1, 2014
Last Update Posted : June 25, 2019
Information provided by (Responsible Party):
Glenn Bauman, Lawson Health Research Institute

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : November 2019